Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 22, No 19 (October 1), 2004: pp. 4020-4022
© 2004 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2004.12.020

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turner, J. E.
Right arrow Articles by Sharpless, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turner, J. E.
Right arrow Articles by Sharpless, N. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

DIAGNOSIS IN ONCOLOGY

Medical Problems in Patients With Malignancy

CASE 2. Wernicke's Encephalopathy: An Unusual Acute Neurologic Complication of Lymphoma and Its Therapy

J. Eric Turner, John G. Alley, Norman E. Sharpless

Lineberger Comprehensive Cancer Center and Departments of Medicine and Radiology, The University of North Carolina School of Medicine, Chapel Hill, NC

A 37-year-old woman presented with retroperitoneal adenopathy, bilateral ureteral obstruction, hydronephrosis, and marked lactic dehydrogenase elevation. A diffuse, large B-cell lymphoma was diagnosed by excisional biopsy. Her initial presentation was also remarkable for protracted, severe nausea that antedated chemotherapy administration. After percutaneous ureteral stenting and nephrostomy tube placement, the patient was treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) plus rituximab (R-CHOP) with a good response. Her ureteral obstruction resolved, and her lactic dehydrogenase level normalized after the first cycle of therapy. She continued to have significant nausea despite aggressive antiemetic therapy, but managed adequate oral intake to avoid dehydration and remain an outpatient. She lost 40 lbs (25% of total body weight) during her first two cycles of chemotherapy, though a portion of this weight-change was related to decreasing edema and tumor burden.

Before her third cycle of R-CHOP, a family member found her obtunded with disconjugate gaze, and she was brought to the emergency department for evaluation. She was afebrile, her electrolytes and calcium were normal, and a lumbar puncture demonstrated no pleocytosis. Emergent magnetic resonance imaging of the brain was performed and demonstrated abnormal enhancement of the floor of the third ventricle and mammillary bodies (Figs 1A and C) —findings consistent with Wernicke's encephalopathy. The patient was treated with intravenous and then oral thiamine, with rapid resolution of her opthalmoplegia and radiographic improvement (Fig. 1B and D). Further questioning of family members revealed that the patient had a significant history of alcohol use, though the patient and family both stated that she had not used alcohol for 3 months before her diagnosis. The patient resumed R-CHOP after major improvement of her confusional state (1 week after thiamine replacement), though return to her baseline cognitive function required 2 additional months after thiamine replacement.



View larger version (146K):
[in this window]
[in a new window]
 
Fig 1.
 
Wernicke's encephalopathy is a medical emergency.1 It is a result of thiamine deficiency. The triad of ophthalmoplegia, ataxia, and global confusion is found in only one-third of presenting patients. Untreated, it can be complicated by coma and death. Some patients do not recover completely, with residual neurologic sequelae that consist of a confabulatory state with impairment in recent memory and learning ("Korsakoff's syndrome"). Wernicke's encephalopathy can be precipitated by the administration of intravenous fluids containing glucose. Thiamine should be administered with fluids to any patient in which the diagnosis is suspected.1 Thiamine deficiency is now rare in the United States, and is predominantly associated with poor diet in the setting of chronic alcohol abuse. Nonalcoholic thiamine deficiency is predominantly associated with prolonged periods of malnourishment, such as in hyperemesis gravidarum or after gastric surgery.2-4 In this patient, the combination of nutritional deficiency related to prior alcohol use, poor dietary intake from her refractory nausea, and high-grade lymphoma, precipitated dramatic but reversible Wernicke's encephalopathy.

Authors' Disclosures of Potential Conflicts of Interest

The authors indicated no potential conflicts of interest.

REFERENCES

1. Reuler JB, Girard DE, Cooney TG: Current concepts: Wernicke's encephalopathy. N Engl J Med 312:1035-1039, 1985[Medline]

2. Abarbanel JM, Berginer VM, Osimani A, et al: Neurologic complications after gastric restriction surgery for morbid obesity. Neurology 37:196-200, 1987[Abstract/Free Full Text]

3. Flannelly G, Turner MJ, Connolly R, et al: Persistent hyperemesis gravidarum complicated by Wernicke's encephalopathy. Ir J Med Sci 159:82, 1990[Medline]

4. Ogershok PR, Rahman A, Nestor S, et al: Wernicke encephalopathy in nonalcoholic patients. Am J Med Sci 323:107-111, 2002[Medline]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turner, J. E.
Right arrow Articles by Sharpless, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turner, J. E.
Right arrow Articles by Sharpless, N. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2004 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online